arrow
V

Venessa Chin

Garvan Institute of Medical Research
H指数:29
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Genetic variants shape single-cell chromatin accessibility and disease risk

遗传变异塑造单细胞染色质可及性和疾病风险

Nature
IF48.5
2026-10-280
OAAI
Real-world treatment sequencing and survival in ROS1-Rearranged NSCLC across evolving treatment eras: Findings from the AURORA multi-centre registry (AURORA-ROS1)

ROS1重排非小细胞肺癌在演变的治疗时代中的真实世界治疗序列与生存情况:AURORA多中心登记研究(AURORA-ROS1)的结果

2026-06-170
PRE
ALKTERNATE: A Pilot Study Alternating Lorlatinib With Crizotinib in ALK-Positive NSCLC With Prior ALK Inhibitor Resistance

ALKTERNATE: 一项在ALK阳性NSCLC中交替使用氯拉替尼和克唑替尼的初步研究

2024-09-010
OA
Application of a revised model for coping with advanced cancer to qualitatively explore lung cancer survivors' experiences of ongoing physical effects, novel treatments, uncertainty, and coping

应用修正的晚期癌症应对模型定性探索肺癌幸存者对持续身体影响,新颖治疗,不确定性和应对的体验

2023-07-275
OAAI
Precision Oncology in Surgery Patient Selection for Operable Pancreatic Cancer
2018-12-1849
OAAI
Deep multi-region whole-genome sequencing reveals heterogeneity and gene-by-environment interactions in treatment-naive, metastatic lung cancer
2018-10-2226
OAAI
Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy
2018-07-2535
OAAI
MASTL overexpression promotes chromosome instability and metastasis in breast cancer
2018-05-1048
OAAI
Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis

通过ROCK抑制的瞬时组织启动可使胰腺癌的进展,对化学疗法的敏感性和转移脱钩

2017-04-05211
OAAI
Hypermutation In Pancreatic Cancer

胰腺癌的超突变

2017-01-01170
OAAI